Critical Resources Claims New LCT Pegmatite System Discoveries at Mavis Lake East
THE DRILL SERGEANT: Critical Resources (ASX: CRR) has claimed discovery of multiple additional spodumene-bearing pegmatites at the company’s 100 per cent-owned Mavis Lake lithium project in Ontario, Canada.
Critical Resources has made the discoveries just weeks into its 2024 Summer Field Exploration Campaign.
The company declared the new finds highlight the potential of the Mavis Lake project to yield further lithium discoveries while validating the recently announced JORC compliant Exploration Target.
Critical Resources kicked off field work comprising prospecting, mapping and sampling in early May, designed to identify new spodumene-bearing pegmatites, determine fractionation trends at the project’s northern prospects and conduct drill pad reconnaissance throughout the Mavis Lake lithium project.
A total of 83 samples were collected from pegmatite outcrops across the broader project area resulting in a total of 31 new pegmatite discoveries.
These include an approx. 250 metres extension of a known spodumene-bearing pegmatite (Pegmatite 20) and 100m extension of the Main Zone spodumene-bearing pegmatite cluster (Pegmatites 7 and 24).
Samples have been prepared and will be dispatched to an independent analytical laboratory in the coming weeks, with full results expected in July/August 2024.
“It’s great to see field teams directly following up our Exploration Target and making further significant discoveries at Mavis Lake at the start of the new field season,” Critical Resources managing director Alex Cheeseman said in the company’s ASX announcement.
“The field program has already increased our confidence in our ability to deliver on the recently published Exploration Target, paving the way for drill testing a number of high-quality targets.
“We look forward to continuing our dual-track strategy of targeting resource growth while progressing our project development and permitting workstreams for Mavis Lake.”
TO READ THE FULL ANNOUNCEMENT: CLICK HERE